Author Details

Криворотько, П. В

Issue Section Title File
No 1S (2009) Articles ANTIANGIOGENNYE PREPARATY V LEChENII RAKA MOLOChNOY ZhELEZY
No 18 (2012) Articles A new approach to the overcoming resistance to hormone therapy of breast cancer
No 17 (2013) Articles Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
No 8 (2016) Articles NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
No 17 (2016) Articles TAXANES IN THE TREATMENT OF BREAST CANCER
No 17 (2017) Articles New possibilities of the treatment of breast cancer: microtubule inhibitors
No 7 (2018) Articles GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
No 12 (2018) Articles Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Vol 27, No 7 (2020) Articles Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
Vol 27, No 7 (2020) Articles Treatment of residual breast cancer
Vol 27, No 7 (2020) Articles Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Vol 29, No 7 (2022) Articles Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
Vol 29, No 7 (2022) Articles Treatment of HER2-positive early (minimal) breast cancer
Vol 29, No 11/12 (2022) Articles The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Vol 29, No 11/12 (2022) Articles Ixabepilone in the treatment of breast cancer

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies